Segall Bryant & Hamill, LLC Collegium Pharmaceutical, Inc Transaction History
Segall Bryant & Hamill, LLC
- $6.35 Billion
- Q1 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 22,515 shares of COLL stock, worth $671,622. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,515
Previous 38,983
42.24%
Holding current value
$671,622
Previous $1.12 Million
39.78%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding COLL
# of Institutions
253Shares Held
37.1MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$173 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$89.5 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$78.7 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$67 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$48.7 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.02B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...